drugset / Trial / NCT04625530

Perioperative Management in Gynaecological Carcinoma Surgery

NCT04625530

RandomizedParallel-groupDouble-blindTreatment

Summary

This study is to determine the effect of perioperative treatment with intravenous iron and tranexamic acid on the reduction of intraoperative and postoperative RBC transfusions in gynaecological carcinoma patients undergoing abdominal surgery.

Timeline

Start
2021-08-01
Primary completion
2026-12-31
Completion
2026-12-31

Drugs

EvaluationDrugModalityDoseRoute
Subject Ferric carboxymaltose Other / unclassified 20 mg/kg Intravenous
Subject Tranexamic Acid Small molecule 1 mg/kg